Saxenda (liraglutide) is a prescription drug that’s used for weight management. Saxenda comes as a liquid solution inside a prefilled injection pen. Saxenda is used to help with weight loss and ...

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

The Advertising Standards Authority (ASA) said ads – one featuring reality TV personality Gemma Collins – could not ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found ...

In 2020, the first weight loss injection available in Britain was Saxenda (or liraglutide). It’s taken once a day with a self-injecting pen, and in trials, around 56 per cent of patients lost 10 ...

Weight loss operations increased in 2022 from the year before, perhaps due to spillover from the COVID-19 pandemic when lockdowns in 2020 and delays in non-emergency operations in 2020 and 2021 ...

The FDA has approved for weight loss GLP-1 drugs Wegovy and Saxenda, which are manufactured by Novo Nordisk, a Danish company. It’s also approved Zepbound, manufactured by Eli Lilly, a U.S. company.

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.